Grant: Doctoral Research Award: Canada Graduate Scholarships
University of British Columbia
$105,000.00
The Multiple Sclerosis Prodrome
EF 2020-21
Résumé
Multiple Sclerosis (MS) is a disease of the brain and spinal cord. Common symptoms include fatigue, vision problems, numbness, weakness and unsteady gait. Canada has one of the highest rates of MS globally. The causes of MS are still not well understood. Many people with MS recall subtle symptoms before the start of typical MS symptoms. These earliest signs of MS are called prodromal symptoms. Much of the research on prodromal symptoms has focused on people who developed MS in adulthood. Recently, researchers have found that adults with MS were more likely to seek health care (i.e. visit a physician, have a hospitalization and fill out prescriptions) for certain conditions (e.g. fatigue and pain) in the 5 years before their first typical MS symptom. However, there are many questions that are still unanswered. During my PhD I will determine (i) what the most common groups of prodromal symptoms among adults with MS are and (ii) whether men and women with MS experience different prodromal symptoms. Five to ten percent of people with MS develop the condition in childhood. Less is known about prodromal symptoms among children with MS. During my PhD I will determine (i) whether children with MS are more likely to seek healthcare for certain conditions in the years before their first typical MS symptom and (ii) whether children with MS are more likely to have lower education scores before their first typical MS symptom. These findings will be important as they may help doctors diagnose MS earlier, allowing people with MS to start MS therapies more promptly. Moreover, once researchers have a better understanding of how far back in time people with MS can experience symptoms, they will be able to investigate the causes of MS better. Lastly, in the future, new therapies will likely be developed that protect the brain and spinal cord. People with prodromal symptoms can then be identified and prescribed these protective therapies.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
439941
Name
Yusuf Fardowsa
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
The Multiple Sclerosis Prodrome
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Biostatistics; Epidemiology; Health Care Utilization; Machine Learning Methods; Multiple Sclerosis; Observational Study; Onset; Pediatric Multiple Sclerosis; Population-Based Data; Prodrome
Abstract
Multiple Sclerosis (MS) is a disease of the brain and spinal cord. Common symptoms include fatigue, vision problems, numbness, weakness and unsteady gait. Canada has one of the highest rates of MS globally. The causes of MS are still not well understood. Many people with MS recall subtle symptoms before the start of typical MS symptoms. These earliest signs of MS are called prodromal symptoms. Much of the research on prodromal symptoms has focused on people who developed MS in adulthood. Recently, researchers have found that adults with MS were more likely to seek health care (i.e. visit a physician, have a hospitalization and fill out prescriptions) for certain conditions (e.g. fatigue and pain) in the 5 years before their first typical MS symptom. However, there are many questions that are still unanswered. During my PhD I will determine (i) what the most common groups of prodromal symptoms among adults with MS are and (ii) whether men and women with MS experience different prodromal symptoms. Five to ten percent of people with MS develop the condition in childhood. Less is known about prodromal symptoms among children with MS. During my PhD I will determine (i) whether children with MS are more likely to seek healthcare for certain conditions in the years before their first typical MS symptom and (ii) whether children with MS are more likely to have lower education scores before their first typical MS symptom. These findings will be important as they may help doctors diagnose MS earlier, allowing people with MS to start MS therapies more promptly. Moreover, once researchers have a better understanding of how far back in time people with MS can experience symptoms, they will be able to investigate the causes of MS better. Lastly, in the future, new therapies will likely be developed that protect the brain and spinal cord. People with prodromal symptoms can then be identified and prescribed these protective therapies.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yusuf, Fardowsa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~